Omron brought a variety of new blood pressure monitors to the Expo

Hypertension is the main risk factor for cardiovascular and cerebrovascular diseases, and is known as the "invisible killer of human health". The Lancet study shows that the number of hypertensive adults aged 30-79 has increased from 650 million to 1.28 billion in the past 30 years. Hypertension is also the leading cause of cardiovascular mortality in China.

This year, Omron Healthcare announced its long-term vision of "Going for ZERO preventive medicine, making the world healthier", and aims to achieve the three "zero" goals of "zero occurrence of cardiovascular and cerebrovascular events", "zero exacerbation of respiratory diseases", and "zero restriction of daily activities due to chronic pain" with long-term accumulated technology and product capabilities. At the CIIE, Omron Health officially released a number of new products, including atrial fibrillation blood pressure monitors, night blood pressure monitors, and Omron intelligent voice management boxes, which is a strong embodiment of Omron Healthcare's advanced products and services towards the goal of "zero cardiovascular and cerebrovascular events".

Omron brought a variety of new blood pressure monitors to the Expo

　　Mr. Masahiro Umeda said, "We believe that how to effectively monitor cardiovascular and cerebrovascular diseases that are susceptible to hypertension while managing blood pressure is an urgent need of consumers and a new issue to be solved in the industry. By providing more diversified and digital products and services, to help improve consumers' awareness of health management and satisfaction with the health management experience, and to promote the progress of blood pressure management concepts in China and even the world, Omron Health Care has been constantly exploring, and it is also the key to whether we can stand at the top of the industry. We believe that diversifying and digitizing blood pressure management is the right path and direction. ”

Blood pressure monitoring has shifted from a single to a new ecology of diversity

The key change brought by Omron's new health care product is to expand the application scenarios and monitoring scope of blood pressure monitoring, extending the risk prediction in the cardiovascular and cerebrovascular fields at the same time as blood pressure monitoring, showing a new layout at the strategic level of chronic disease management.

Relevant studies have shown that hypertension is the main cause of atrial fibrillation, and early screening of atrial fibrillation at the same time as blood pressure management is of great significance for the prevention of heart and brain diseases. Therefore, Omron Health has launched a new product of atrial fibrillation blood pressure monitor, HEM-7361T, which uses the function of three consecutive blood pressure measurements, when the irregular pulse wave appears more than twice, there may be the possibility of atrial fibrillation. The sensitivity and specificity of this atrial fibrillation blood pressure monitor have been verified in clinical trials at Kagawa University in Japan, and can fully provide value to users who need to detect blood pressure and atrial fibrillation. In response to nocturnal hypertension, which is highly associated with cardiovascular diseases, Omron Health also released the nighttime wrist sphygmomanometer HEM-9601T1, which can automatically measure blood pressure while the user is asleep, actively record and transmit data, and complete the nighttime hypertension risk screening through three automatic blood pressure monitoring in the user's bedroom. Omron Health also compared a total of 694 nighttime blood pressure measurements automatically measured during sleep between a common upper arm home blood pressure monitor and a wrist-based night blood pressure monitor in 50 patients with high blood pressure, and found that the values were basically the same.

　　Professor Wang Jiguang, Chairman of the China Hypertension Alliance, Director of the Department of Hypertension of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, and Director of the Shanghai Institute of Hypertension, said that there are currently about 7.9 million patients with atrial fibrillation in China, which brings a heavy medical burden to the public health system. The harm of atrial fibrillation is mainly manifested in increasing the risk of stroke and dementia, forming a vicious circle with heart failure, increasing the prevalence of heart failure, aggravating the symptoms of heart failure, and increasing mortality. Therefore, hypertension is an important factor in increasing the risk of atrial fibrillation, and blood pressure control should be part of the overall management of patients with atrial fibrillation. The one-step completion of blood pressure measurement and atrial fibrillation screening can expand the population and frequency of atrial fibrillation screening, and effectively improve the screening rate of atrial fibrillation in hypertensive people. Blood pressure management needs digital platforms to empower and help, such as Omron Healthcare's atrial fibrillation sphygmomanometer HEM-7361T and wrist sphygmomanometer HEM-9601T1 at night, which can comprehensively help assess cardiovascular status and target organ lesions, predict the risk of cardiovascular events, and make positive contributions to the standardization, informatization and automation of hypertension management in iHEC Intelligent Hypertension Diagnosis and Treatment Center.

The management of chronic diseases, represented by hypertension, requires more innovative and diversified management equipment and service support. Omron's new health care products can effectively help users monitor cardiovascular and cerebrovascular diseases simultaneously, truly link family health management and medical sites, meet the blood pressure health management needs of different consumer groups, and create a new ecology of diversified blood pressure management for the industry.

Innovate a new experience of digital chronic disease management

With the development of communication technology and the popularization of home-based portable devices, digital self-health management tools have become a new choice for many chronic disease users.

At the CIIE, Omron Health Medical not only released a number of new blood pressure monitor products, but also launched a black technology that innovates the new experience of digital chronic disease management - Omron intelligent voice management box. It is understood that this product will bring a lot of convenience to users of chronic diseases in terms of health data management and telemedicine services.

　　At the level of health data management, the professional management system of Omron intelligent voice management box is connected with the health data of various products of Omron Healthcare, so that consumers can upload multiple data such as blood pressure and blood sugar in time to intelligently track their physical health status in real time. In addition to supporting blood glucose, blood pressure dual measurement and multi-person health monitoring management, Omron intelligent voice management box also has medical functions such as generating monthly health weekly reports, equipped with medication records and real-time push of abnormal data, as well as regular updates of expert popular science content, free on-demand video and audio entertainment and other multiple life functions, bringing consumers a new experience of digital family health management.

At the level of future-oriented telemedicine services, Omron's intelligent voice management box will use AI to analyze the collected data to help establish users' personal chronic disease management files, and at the same time break the space limitations of traditional medical treatment through telemedicine, effectively integrate top medical expert resources, so that patients can easily communicate with pharmacies and doctors without leaving home, complete medication guidance and consultation, and enjoy high-quality medical services at home. Omron Health believes that "digital" blood pressure management has changed from the original "optional" to "mandatory", and the Omron intelligent voice management box with telemedicine services can not only reduce the burden of medical treatment for the masses and improve the medical experience, but also help patients with chronic diseases to improve their understanding of their own health, and further provide more basis for the judgment and decision-making of hospitals and doctors.

Omron Healthcare has accumulated nearly half a century of experience in the field of blood pressure management, and its cumulative global sales have exceeded 300 million units. This time, with the help of the national platform of the CIIE, the launch of heavyweight new scientific and technological products also demonstrates the company's innovation vitality and scientific research strength, which is of positive strategic significance for promoting the comprehensive prevention and control management of cardiovascular and cerebrovascular diseases in China and accelerating the process of digital medicine. Adhering to the long-term vision of "Going for ZERO preventive medicine, making the world healthier", Omron Healthcare will continue to focus on innovative technology, continue to make efforts on the road of Internet of Everything and digital healthcare, build a diversified and digital new health care ecosystem, and empower the high-quality development of China's blood pressure management industry.

Omron brought a variety of new blood pressure monitors to the Expo

Sections viewed

Contact

working hours